Get the Stockscreener App
20.19
3.43%
0.67
After Hours:
20.19
Arrivent Biopharma Inc stock is traded at $20.19, with a volume of 477.30K.
It is up +3.43% in the last 24 hours and up +3.80% over the past month.
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
See More
Previous Close:
$19.52
Open:
$19.52
24h Volume:
477.30K
Relative Volume:
1.40
Market Cap:
$819.09M
Revenue:
-
Net Income/Loss:
$-136.98M
P/E Ratio:
-5.0224
EPS:
-4.02
Net Cash Flow:
$-126.63M
1W Performance:
+5.60%
1M Performance:
+3.80%
6M Performance:
-10.15%
1Y Performance:
-24.10%
1-Day Range:
$19.31
$20.45
1-Week Range:
$18.39
$20.63
52-Week Range:
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Name
Arrivent Biopharma Inc
Sector
Industry
Phone
240-780-6356
Address
18 CAMPUS BLVD., NEWTOWN SQUARE
Compare AVBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
20.19 | 791.91M | 0 | -136.98M | -126.63M | -4.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Resumed | Goldman | Buy |
| Mar-20-25 | Initiated | B. Riley Securities | Buy |
| Mar-10-25 | Initiated | Guggenheim | Buy |
| Jul-22-24 | Initiated | Oppenheimer | Outperform |
| Apr-30-24 | Initiated | H.C. Wainwright | Buy |
| Feb-20-24 | Initiated | Citigroup | Buy |
| Feb-20-24 | Initiated | Goldman | Buy |
| Feb-20-24 | Initiated | Jefferies | Buy |
View All
Arrivent Biopharma Inc Stock (AVBP) Latest News
Will breakout in ArriVent BioPharma Inc. lead to full recoveryJuly 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
Automated trading signals detected on ArriVent BioPharma Inc.2025 Trade Ideas & Weekly Watchlist for Hot Stocks - Newser
Does ArriVent BioPharma Inc. have pricing powerPortfolio Update Report & Technical Confirmation Trade Alerts - خودرو بانک
Real time breakdown of ArriVent BioPharma Inc. stock performanceQuarterly Profit Review & Fast Exit and Entry Strategy Plans - Newser
Regression analysis insights on ArriVent BioPharma Inc. performance2025 Volatility Report & Weekly Hot Stock Watchlists - Newser
Institutional scanner results for ArriVent BioPharma Inc.July 2025 Market Mood & Community Consensus Stock Picks - Newser
Will ArriVent BioPharma Inc. stock go up in YEAR2025 Top Gainers & Technical Confirmation Alerts - خودرو بانک
Historical volatility pattern of ArriVent BioPharma Inc. visualizedEarnings Overview Report & Technical Pattern Based Signals - Newser
Will ArriVent BioPharma Inc. benefit from rising consumer demandWeekly Market Report & Safe Entry Momentum Stock Tips - خودرو بانک
Can ArriVent BioPharma Inc. Escape Recent Bear ChannelTrend Reversal & Accurate Buy Signal Notifications - beatles.ru
Backtesting results for ArriVent BioPharma Inc. trading strategiesMarket Activity Recap & Stepwise Entry and Exit Trade Signals - Newser
Can ArriVent BioPharma Inc. hit a new high this monthIPO Watch & Risk Controlled Swing Alerts - Newser
Will ArriVent BioPharma Inc. benefit from macro trendsTrade Entry Report & Risk Managed Investment Strategies - Newser
What machine learning models say about ArriVent BioPharma Inc.July 2025 Sector Moves & Real-Time Market Sentiment Alerts - Newser
What’s the analyst consensus on ArriVent BioPharma Inc.2025 Macro Impact & Weekly High Return Stock Forecasts - خودرو بانک
Is ArriVent BioPharma Inc. showing signs of accumulationJuly 2025 Trade Ideas & Stock Timing and Entry Methods - Newser
Is this a good reentry point in ArriVent BioPharma Inc.Weekly Stock Recap & Precise Entry and Exit Recommendations - Newser
Is ArriVent BioPharma Inc. stock bottoming outFed Meeting & Real-Time Buy Signal Alerts - Newser
Published on: 2025-09-04 00:41:04 - Newser
Published on: 2025-09-04 08:31:42 - خودرو بانک
Smart tools for monitoring ArriVent BioPharma Inc.’s price actionQuarterly Growth Report & Long-Term Capital Growth Ideas - Newser
Advanced analytics toolkit walkthrough for ArriVent BioPharma Inc.Analyst Downgrade & Risk Managed Trade Strategies - Newser
Institutional Tools Highlight Unusual Flow in ArriVent BioPharma Inc.July 2025 Movers & Weekly Breakout Stock Alerts - beatles.ru
Full technical analysis of ArriVent BioPharma Inc. stockEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
Earnings visualization tools for ArriVent BioPharma Inc.Fed Meeting & Technical Confirmation Alerts - Newser
Nuveen LLC Takes $819,000 Position in ArriVent BioPharma, Inc. $AVBP - Defense World
How high can ArriVent BioPharma Inc. stock goDip Buying & Free Fast Entry Momentum Trade Alerts - Newser
Will ArriVent BioPharma Inc. outperform the marketJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
Understanding ArriVent BioPharma Inc.’s price movement2025 Price Momentum & Scalable Portfolio Growth Methods - Newser
What to expect from ArriVent BioPharma Inc. in the next 30 daysJuly 2025 Fed Impact & Precise Buy Zone Tips - Newser
Is now a turning point for SmartKem Inc.July 2025 Market Mood & Breakout Confirmation Alerts - Newser
Watch for Bullish Crossover in ArriVent BioPharma Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Analyzing recovery setups for ArriVent BioPharma Inc. investors2025 Dividend Review & Community Consensus Trade Signals - Newser
What recovery options are there for ArriVent BioPharma Inc.July 2025 Trade Ideas & Weekly High Conviction Trade Ideas - Newser
Risk adjusted return profile for ArriVent BioPharma Inc. analyzedPortfolio Update Summary & Proven Capital Preservation Methods - Newser
Arrivent Biopharma Inc Stock (AVBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):